ACP
Acuta Capital Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $866K | Buy |
23,814
+2,524
| +12% | +$91.8K | 1.21% | 22 |
|
|
2025
Q1 | $771K | Buy |
21,290
+290
| +1% | +$10.5K | 0.89% | 27 |
|
|
2024
Q4 | $883K | Sell |
21,000
-4,100
| -16% | -$172K | 0.89% | 29 |
|
|
2024
Q3 | $1.39M | Buy |
+25,100
| New | +$1.39M | 1.13% | 25 |
|
|
2024
Q2 | – | Sell |
-20,000
| Closed | -$934K | – | 39 |
|
|
2024
Q1 | $934K | Buy |
+20,000
| New | +$934K | 0.61% | 30 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 58 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 54 |
|